批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/04/27 |
SUPPL-58(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/04/27 |
SUPPL-55(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/07/26 |
SUPPL-54(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/04/27 |
SUPPL-47(补充) |
Approval |
Labeling |
|
|
|
2010/01/25 |
SUPPL-43(补充) |
Approval |
Labeling |
|
|
|
2009/01/29 |
SUPPL-37(补充) |
Approval |
Labeling |
|
|
|
2001/04/25 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
2001/03/22 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1999/09/14 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/12/21 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/12/21 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/12/21 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1997/06/20 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/12/19 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/12/19 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/12/19 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/12/19 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/01/28 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1990/06/29 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1989/12/20 |
SUPPL-15(补充) |
Approval |
Bioequivalence |
|
|
|
1988/10/27 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
1988/04/01 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1986/01/07 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1985/07/05 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1985/07/05 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1984/03/29 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1983/04/21 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1982/04/20 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:CARISOPRODOL 剂型/给药途径:TABLET;ORAL 规格:350MG 治疗等效代码:AA
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
011792 |
001 |
NDA |
SOMA |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
Yes |
No |
AA |
Approved Prior to Jan 1, 1982
|
MYLAN SPECIALITY LP |
087499 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
1982/04/20
|
WATSON LABS |
081025 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
1989/04/13
|
WANBANG BIOPHARMS |
040188 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
1997/03/07
|
OXFORD PHARMS |
040245 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
1997/09/08
|
CHARTWELL RX |
040576 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
2005/06/07
|
ACCELRX LABS |
040823 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
2008/10/22
|
NOVAST LABS |
040792 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
2009/08/06
|
AUROBINDO PHARMA |
203374 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
2014/01/27
|
SCIEGEN PHARMS INC |
205085 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
2014/10/28
|
ORIENT PHARMA CO LTD |
090988 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
2014/10/28
|
NATCO |
205126 |
002 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
2015/07/08
|
CHARTWELL RX |
207237 |
002 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Prescription |
No |
No |
AA |
2020/09/21
|
NOSTRUM LABS INC |
211789 |
001 |
ANDA |
CARISOPRODOL |
CARISOPRODOL |
TABLET;ORAL |
350MG |
Discontinued |
No |
No |
AA |
2021/10/20
|
ALLIED |